Aripiprazole Monotherapy and Adjunctive Therapy for the Treatment of Psychosis and Mood Instability

Course overview

Aripiprazole is an atypical antipsychotic that is indicated for an array of psychiatric disease states. Being commonly known as a dopamine system stabilizer (DSS), aripiprazole is a first-line treatment option for adults diagnosed with schizophrenia, Bipolar I disorder, and major depressive disorder (MDD). Additionally, it may be utilized in children greater than six years of age with irritability associated with autism or tics secondary to Tourette's syndrome. Aripiprazole is unique among atypical antipsychotics due to the characteristics discussed below. Evidence exists in the literature to suggest that aripiprazole has potential neuroprotective effects.